Novartis AG (TSX:NVS)
Canada · Delayed Price · Currency is CAD 28.45
+0.45 (1.61%)
Oct 9, 2026, 10:39 AM EST
Novartis AG Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 388,776 | 363,637 | 281,574 | 273,591 | 263,170 | 249,311 | |
Market Cap Growth | 8.30% | 29.14% | 2.92% | 3.96% | 5.56% | -9.01% |
Enterprise Value | 446,780 | 395,040 | 306,296 | 291,453 | 276,969 | 283,488 |
Last Close Price | 28.45 | 25.35 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.46 | 18.97 | 16.39 | 13.95 | 27.96 | 8.20 |
PS Ratio | 4.83 | 4.68 | 3.78 | 4.44 | 4.47 | 4.48 |
PB Ratio | 6.53 | 5.70 | 4.43 | 4.43 | 3.27 | 2.91 |
P/TBV Ratio | - | - | - | - | - | 21.01 |
P/FCF Ratio | 16.33 | 15.07 | 12.04 | 15.46 | 14.60 | 14.07 |
P/OCF Ratio | 14.88 | 13.85 | 11.11 | 14.33 | 13.66 | 13.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.68 | 5.08 | 4.12 | 4.73 | 4.71 | 5.09 |
EV/EBITDA Ratio | 13.77 | 12.27 | 10.30 | 12.15 | 14.68 | 14.33 |
EV/EBIT Ratio | 17.35 | 15.16 | 13.04 | 21.57 | 22.21 | 20.43 |
EV/FCF Ratio | 18.77 | 16.37 | 13.10 | 16.47 | 15.36 | 16.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.17 | 0.76 | 0.71 | 0.57 | 0.47 | 0.46 |
Debt / EBITDA Ratio | 2.10 | 1.49 | 1.50 | 1.44 | 1.97 | 1.95 |
Debt / FCF Ratio | 2.92 | 2.02 | 1.93 | 1.97 | 2.10 | 2.22 |
Net Debt / Equity Ratio | 0.99 | 0.51 | 0.41 | 0.27 | 0.16 | 0.04 |
Net Debt / EBITDA Ratio | 1.79 | 1.02 | 0.87 | 0.68 | 0.66 | 0.18 |
Net Debt / FCF Ratio | 2.47 | 1.36 | 1.11 | 0.92 | 0.69 | 0.21 |
Asset Turnover | 0.50 | 0.53 | 0.51 | 0.43 | 0.35 | 0.34 |
Inventory Turnover | 2.27 | 2.27 | 2.20 | 1.91 | 1.67 | 1.65 |
Quick Ratio | 0.55 | 0.82 | 0.78 | 0.88 | 1.00 | 1.25 |
Current Ratio | 0.86 | 1.12 | 1.03 | 1.16 | 1.29 | 1.51 |
Return on Equity (ROE) | 30.35% | 30.81% | 26.27% | 16.15% | 9.51% | 36.80% |
Return on Assets (ROA) | 10.25% | 11.14% | 10.09% | 5.88% | 4.62% | 5.28% |
Return on Invested Capital (ROIC) | 18.78% | 24.47% | 23.55% | 15.05% | 11.14% | 13.29% |
Return on Capital Employed (ROCE) | 20.60% | 22.70% | 22.20% | 13.90% | 10.40% | 10.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.66% | 5.27% | 6.10% | 7.17% | 3.58% | 12.19% |
FCF Yield | 6.12% | 6.64% | 8.30% | 6.47% | 6.85% | 7.11% |
Dividend Yield | 3.06% | 25.23% | - | - | - | - |
Payout Ratio | 71.08% | 55.91% | 63.85% | 48.85% | 107.92% | 30.67% |
Buyback Yield / Dilution | 3.33% | 3.93% | 2.73% | 4.78% | 2.79% | 1.57% |
Total Shareholder Return | 6.40% | 29.17% | 2.73% | 4.78% | 2.79% | 1.57% |